Helal F Hetta1,2, Mohamed A Mekky3, Nasr K Khalil4, Wegdan A Mohamed2, Mohamed A El-Feky2, Shabaan H Ahmed2, Enas A Daef2, Mahmoud I Nassar5, Ahmed Medhat3, Kenneth E Sherman1, Mohamed Tarek M Shata1. 1. Department of Internal Medicine, Division of Digestive Diseases, University of Cincinnati, Cincinnati, Ohio, USA. 2. Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt. 3. Department of Gastroenterology and Tropical Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt. 4. Assiut Liver Institute for Treatment of Hepatitis C, Assiut, Egypt. 5. Department of Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Abstract
BACKGROUND AND AIM: Forkhead box protein P3 (FoxP3)(+) regulatory T (Treg ) cells play a fundamental role in maintaining the balance between the tissue-damaging and protective immune response to chronic hepatitis C (CHC) infection. Herein, we investigated the frequency of Treg cells in the colon and their potential relationship to the various CHC outcomes and hepatic histopathology. METHODS: Colonic biopsies were collected from three groups with CHC: treatment naïve (TN; n = 20), non-responders (NR; n = 20), sustained virologic response (SVR; n = 20), and a fourth healthy control group (n = 10). The plasma viral loads and cytokines levels were determined by quantitative real-time polymerase chain reaction, and ELISA, respectively. Liver biopsies were examined to assess inflammatory score and fibrosis stage. Colonic Treg frequency was estimated by immunohistochemistry using confocal microscopy. RESULTS: A significant increase in the frequency of colonic Treg was found in TN, and NR groups compared with the control and SVR group. The frequency of colonic Treg , plasma interleukin (IL)-10 and IL-4 levels were significantly positively correlated with viral load and negatively correlated with METAVIR inflammatory score, and fibrosis stages. CONCLUSION: Colonic Treg cells are negatively correlated with liver inflammation and hepatitis C virus (HCV) viral load, which suggests a strong linkage between gut-derived Treg cell populations and HCV infection.
BACKGROUND AND AIM: Forkhead box protein P3 (FoxP3)(+) regulatory T (Treg ) cells play a fundamental role in maintaining the balance between the tissue-damaging and protective immune response to chronic hepatitis C (CHC) infection. Herein, we investigated the frequency of Treg cells in the colon and their potential relationship to the various CHC outcomes and hepatic histopathology. METHODS: Colonic biopsies were collected from three groups with CHC: treatment naïve (TN; n = 20), non-responders (NR; n = 20), sustained virologic response (SVR; n = 20), and a fourth healthy control group (n = 10). The plasma viral loads and cytokines levels were determined by quantitative real-time polymerase chain reaction, and ELISA, respectively. Liver biopsies were examined to assess inflammatory score and fibrosis stage. Colonic Treg frequency was estimated by immunohistochemistry using confocal microscopy. RESULTS: A significant increase in the frequency of colonic Treg was found in TN, and NR groups compared with the control and SVR group. The frequency of colonic Treg , plasma interleukin (IL)-10 and IL-4 levels were significantly positively correlated with viral load and negatively correlated with METAVIR inflammatory score, and fibrosis stages. CONCLUSION:Colonic Treg cells are negatively correlated with liver inflammation and hepatitis C virus (HCV) viral load, which suggests a strong linkage between gut-derived Treg cell populations and HCV infection.
Authors: F Bolacchi; A Sinistro; C Ciaprini; F Demin; M Capozzi; F C Carducci; C M J Drapeau; G Rocchi; A Bergamini Journal: Clin Exp Immunol Date: 2006-05 Impact factor: 4.330
Authors: Scott M Ward; Julie R Jonsson; Sophie Sierro; Andrew D Clouston; Michaela Lucas; Ana L Vargas; Elizabeth E Powell; Paul Klenerman Journal: Eur J Immunol Date: 2004-06 Impact factor: 5.532
Authors: Yoav Keynan; Catherine M Card; Paul J McLaren; Magdy R Dawood; Ken Kasper; Keith R Fowke Journal: Clin Infect Dis Date: 2008-04-01 Impact factor: 9.079
Authors: B Langhans; M Lechmann; H Ihlenfeldt; G Jung; G Giers; S Schweitzer; M El Bakri; T Sauerbruch; U Spengler Journal: Eur J Med Res Date: 2000-03-27 Impact factor: 2.175
Authors: Tobias Boettler; Hans Christian Spangenberg; Christoph Neumann-Haefelin; Elisabeth Panther; Simonetta Urbani; Carlo Ferrari; Hubert E Blum; Fritz von Weizsäcker; Robert Thimme Journal: J Virol Date: 2005-06 Impact factor: 5.103
Authors: Bertus Eksteen; Allister J Grant; Alice Miles; Stuart M Curbishley; Patricia F Lalor; Stefan G Hübscher; Michael Briskin; Mike Salmon; David H Adams Journal: J Exp Med Date: 2004-11-22 Impact factor: 14.307
Authors: Helal F Hetta; Mohamed A Mekky; Nasr K Khalil; Wegdan A Mohamed; Mohamed A El-Feky; Shabaan H Ahmed; Enas A Daef; Ahmed Medhat; Mahmoud I Nassar; Kenneth E Sherman; Mohamed Tarek M Shata Journal: J Med Microbiol Date: 2016-05-10 Impact factor: 2.472
Authors: Asmaa M Zahran; Zeinab Albadry M Zahran; Omnia El-Badawy; Mona H Abdel-Rahim; Wageeh A M Ali; Amal Rayan; Muhammad Abbas El-Masry; Mohamed A A Abozaid; Helal F Hetta Journal: Immunol Res Date: 2019-06 Impact factor: 2.829
Authors: Ramazan Dertli; Mehmet Asil; Murat Bıyık; Ahmet Karakarcayıldız; Muharrem Keskin; Yusuf Kayar; Müşerref Başdemirci; Hüseyin Ataseven Journal: Turk J Gastroenterol Date: 2021-07 Impact factor: 1.852
Authors: Minesh Mehta; Helal F Hetta; Enass A Abdel-Hameed; Susan D Rouster; MdMonir Hossain; Mohamed A Mekky; Nasr K Khalil; Wegdan A Mohamed; Mohamed A El-Feky; Shabaan H Ahmed; Enas A Daef; Mohamed A El-Mokhtar; Sayed F Abdelwahab; Ahmed Medhat; Kenneth E Sherman; Mohamed Tarek M Shata Journal: Arch Virol Date: 2016-08-20 Impact factor: 2.574
Authors: Noura H Abd Ellah; Esraa A Ahmed; Rasha B Abd-Ellatief; Marwa F Ali; Asmaa M Zahran; Helal F Hetta Journal: Int J Nanomedicine Date: 2019-04-03
Authors: Hala Rady Ahmed; Nancy G F M Waly; Rehab Mahmoud Abd El-Baky; Ramadan Yahia; Helal F Hetta; Amr M Elsayed; Reham Ali Ibrahem Journal: PLoS One Date: 2021-04-15 Impact factor: 3.240
Authors: Mohamed A Mekky; Hani I Sayed; Mohamed O Abdelmalek; Medhat A Saleh; Osman A Osman; Heba A Osman; Khairy H Morsy; Helal F Hetta Journal: Infect Drug Resist Date: 2019-01-22 Impact factor: 4.003
Authors: Godfred Fugtagbi; Paulina S Otu; Mubarak Abdul-Rahman; Ebenezer K Aidoo; Aminata C Lo; Ben A Gyan; Yaw A Afrane; Linda E Amoah Journal: Genet Res (Camb) Date: 2022-02-28 Impact factor: 1.375